FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

INMED PHARMACEUTICALS INC.: revenue

One fact, its scope and the complete path back to the official record.

Period: 2023-07-01 – 2024-06-30Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/8c0dac47-7b76-4ab7-9edd-bdee07d9b706

Reported value

$4.598M{"amount": 4597730, "concept": "us-gaap:Revenues", "currency": "USD"}
Entity
INMED PHARMACEUTICALS INC.
Metric
revenue
Period
2023-07-01 – 2024-06-30
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001213900-24-082843 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:40:39.452018+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001728328/revenue/2024-06-30 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.